243 related articles for article (PubMed ID: 15535854)
1. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.
Guillemette C; Bélanger A; Lépine J
Breast Cancer Res; 2004; 6(6):246-54. PubMed ID: 15535854
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue.
Chouinard S; Tessier M; Vernouillet G; Gauthier S; Labrie F; Barbier O; Bélanger A
Mol Pharmacol; 2006 Mar; 69(3):908-20. PubMed ID: 16339389
[TBL] [Abstract][Full Text] [Related]
3. Disturbance of Mammary UDP-Glucuronosyltransferase Represses Estrogen Metabolism and Exacerbates Experimental Breast Cancer.
Zhou X; Zheng Z; Xu C; Wang J; Min M; Zhao Y; Wang X; Gong Y; Yin J; Guo M; Guo D; Zheng J; Zhang B; Yin X
J Pharm Sci; 2017 Aug; 106(8):2152-2162. PubMed ID: 28479355
[TBL] [Abstract][Full Text] [Related]
4. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
5. Glucuronidation of hydroxylated polybrominated diphenyl ethers and their modulation of estrogen UDP-glucuronosyltransferases.
Lai Y; Lu M; Lin S; Cai Z
Chemosphere; 2012 Feb; 86(7):727-34. PubMed ID: 22119418
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of estradiol glucuronidation: a protective mechanism against estradiol-mediated carcinogenesis?
Pfeiffer E; Graf E; Gerstner S; Metzler M
Mol Nutr Food Res; 2006 Apr; 50(4-5):385-9. PubMed ID: 16598814
[TBL] [Abstract][Full Text] [Related]
7. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
Lépine J; Bernard O; Plante M; Têtu B; Pelletier G; Labrie F; Bélanger A; Guillemette C
J Clin Endocrinol Metab; 2004 Oct; 89(10):5222-32. PubMed ID: 15472229
[TBL] [Abstract][Full Text] [Related]
8. The influence of metabolism on the genotoxicity of catechol estrogens in three cultured cell lines.
Gerstner S; Glasemann D; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2008 Jul; 52(7):823-9. PubMed ID: 18618478
[TBL] [Abstract][Full Text] [Related]
9. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis.
Bock KW
Crit Rev Biochem Mol Biol; 1991; 26(2):129-50. PubMed ID: 1914494
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
Lehmann L; Wagner J
Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
[TBL] [Abstract][Full Text] [Related]
11. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
12. Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.
Bock KW; Köhle C
Biochem Pharmacol; 2009 May; 77(9):1458-65. PubMed ID: 19150343
[TBL] [Abstract][Full Text] [Related]
13. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
[TBL] [Abstract][Full Text] [Related]
14. Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
Thibaudeau J; Lépine J; Tojcic J; Duguay Y; Pelletier G; Plante M; Brisson J; Têtu B; Jacob S; Perusse L; Bélanger A; Guillemette C
Cancer Res; 2006 Jan; 66(1):125-33. PubMed ID: 16397224
[TBL] [Abstract][Full Text] [Related]
15. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
[TBL] [Abstract][Full Text] [Related]
17. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
18. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
[TBL] [Abstract][Full Text] [Related]
19. In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases.
Ruefer CE; Gerhäuser C; Frank N; Becker H; Kulling SE
Mol Nutr Food Res; 2005 Sep; 49(9):851-6. PubMed ID: 16092069
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
